REGENXBIO Inc.

In News

Regenxbio stock surges on director share purchases By Investing.com - Investing.com South Africa

Investing.com South Africa - Aug 28, 2026

FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome - Reuters

Reuters - Aug 24, 2026

REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli - PR Newswire

PR Newswire - Aug 25, 2026

Regenxbio’s Second Clinical Hold in Eight Months Exposes a Safety Monitoring System That Was Never Rebuilt After the First One - The Clinical Trial Vanguard

The Clinical Trial Vanguard - Aug 25, 2026

Safety concerns spur FDA to again halt testing of Regenxbio gene therapy - BioPharma Dive

BioPharma Dive - Aug 24, 2026

Regenxbio: Sell-Off On Hunter Setback Presents A Risky Buy Opportunity (NASDAQ:RGNX) - Seeking Alpha

Seeking Alpha - Aug 25, 2026

RGNX Investor Notice: Johnson Fistel Investigates REGENXBIO Inc. Following Clinical Hold - GlobeNewswire

GlobeNewswire - Aug 24, 2026

Regenxbio director Ciongoli buys $949,381 in RGNX stock - Investing.com

Investing.com - Aug 28, 2026

Regenxbio Inc (RGNX) Insider Gregory Ciongoli Purchases 102,603 Shares - GuruFocus

GuruFocus - Aug 28, 2026

Spinal MRI findings trigger FDA hold, derail RegenxBio’s RGX-121 filing - AllSci

AllSci - Aug 24, 2026

REGENXBIO (RGNX) grants $550K equity to new board hire - Stock Titan

Stock Titan - Aug 25, 2026

REGENXBIO Shares Plunge After FDA Places Clinical Hold on RGX-121 - Yahoo Finance

Yahoo Finance - Aug 24, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment